Comments to FDA: Postmarketing Safety Reports for Human Drug and Biological Products

Docket Number:

FDA-2008-N-0334

Comments regarding a proposed rule on electronic submission requirements for postmarketing safety reports for human drug and biological products.

Issues:

OTC Medicines